Log in
0 followers
reMYND drives the development of disease-modifying treatments against protein misfolding disorders.
Industries
Headquarters
Employees
Links
Koen De Witte
9 members
3 members
Motive
17 followers
Collibra
27 followers
Australian Medical Students' Association
189 followers
Cisco
1092 followers
Aliaxis
Discover companies
